糖尿病用注射ペンの市場：製品、用途、流通チャネル別-2025-2030年の世界予測

糖尿病用注射ペン市場は、2023年に165億米ドルと評価され、2024年には174億6,000万米ドルに達すると予測され、CAGR 5.87%で成長し、2030年には246億1,000万米ドルに達すると予測されています。

糖尿病用注射ペン市場には、インスリンやその他の糖尿病治療薬を投与するためのデバイスが含まれます。これらのペンは、正確な投与、使いやすさ、糖尿病管理に不可欠なコンプライアンスの向上を提供します。これらのペンの必要性は、世界の糖尿病有病率の上昇、人口の高齢化、従来の注射器と比較して侵襲的でない投与方法を好む患者の嗜好によって推進されています。用途別では、これらのペンは1型糖尿病患者や2型糖尿病患者に広く使用されており、使い捨てタイプと再利用可能タイプがあります。主なエンドユーザーには、病院、診療所、在宅介護の現場などがあります。市場開拓は、使いやすさと正確さを向上させるペン技術の進歩、糖尿病管理に対する消費者の意識の高まり、新興国市場におけるヘルスケアインフラの拡大といった要因に影響されています。最近のビジネスチャンスは、モバイルアプリと同期して投与パターンを追跡するBluetooth対応ペンなどの技術統合によってもたらされており、企業に有利な見通しをもたらしています。さらに、バイオ医薬品を送達できるペンの開発は、技術革新の新たな道を示しています。しかし、糖尿病治療に伴う高額な費用、厳しい規制要件、注射針恐怖症や潜在的な副作用に対する懸念が市場成長の課題となっています。企業は、競争力を維持するために、デジタル・ソリューションを統合した費用対効果が高く使いやすい機器の開発に注力すべきです。針を使わない選択肢や生物製剤送達の研究に投資することで、新たな収益源を開拓することもできます。こうした課題にもかかわらず、各社が製品の多様化や戦略的提携を通じて機会を活用することで、市場の着実な成長が見込まれます。市場が進化を続ける中、カスタマイズと患者中心のソリューションの採用は、未開拓のセグメントを取り込み、事業成長を促進する鍵となると思われます。全体として、市場の競争は激しく、急速な進歩が拡大や革新の大きな可能性を予感させる。

市場力学：急速に進化する糖尿病用注射ペン市場の主要市場インサイトを公開

糖尿病用注射ペン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の糖尿病患者の増加
  • インテリジェントインスリンペンの需要
  • 再利用可能な糖尿病用注射ペンの採用拡大
• 市場抑制要因
  • 特定の種類のインスリンをペンで使用することの制限
• 市場機会
  • eコマースによる容易な入手と利便性
  • 先進的な糖尿病用注射ペンのイントロダクション
• 市場の課題
  • 不適切な使用による感染リスク

ポーターの5つの力：糖尿病用注射ペン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、糖尿病用注射ペン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：糖尿病用注射ペン市場における外部からの影響の把握

外部マクロ環境要因は、糖尿病用注射ペン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析糖尿病用注射ペン市場における競合情勢の把握

糖尿病用注射ペン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス糖尿病用注射ペン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、糖尿病用注射ペン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨糖尿病用注射ペン市場における成功への道筋を描く

糖尿病用注射ペン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で糖尿病患者の有病率が上昇
    • インテリジェントインスリンペンの需要
    • 再利用可能な糖尿病注射ペンの採用増加
  • 抑制要因
    • 特定の種類のインスリンをペンで使用した場合の制限
  • 機会
    • eコマースチャネルを通じて簡単に入手でき、便利
    • 高度な糖尿病用注射ペンのイントロダクション
  • 課題
    • 不適切な使用による感染のリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 糖尿病用注射ペンの市場：製品別

• インスリンペン
• ペン針

第7章 糖尿病用注射ペンの市場用途別

• 使い捨て
• 再利用可能

第8章 糖尿病用注射ペンの市場：流通チャネル別

• 糖尿病クリニック
• 病院薬局
• オンライン販売
• 小売薬局

第9章 南北アメリカの糖尿病用注射ペンの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の糖尿病用注射ペンの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの糖尿病用注射ペンの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca PLC
• Becton, Dickinson, and Company
• Biocon Limited
• Dexcom Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Haselmeier GmbH
• Jiangsu Delfu Medical Device Co., Ltd.
• Medtronic PLC
• Merck KGaA
• Novartis AG
• Novo Nordisk A/S
• Owen Mumford Limited
• Pfizer Inc.
• Sanofi S.A.
• Ypsomed Holding AG

LIST OF FIGURES

• FIGURE 1. DIABETES INJECTION PENS MARKET RESEARCH PROCESS
• FIGURE 2. DIABETES INJECTION PENS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIABETES INJECTION PENS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIABETES INJECTION PENS MARKET DYNAMICS
• TABLE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. CHINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. INDIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. ITALY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. POLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. QATAR DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023

The Diabetes Injection Pens Market was valued at USD 16.50 billion in 2023, expected to reach USD 17.46 billion in 2024, and is projected to grow at a CAGR of 5.87%, to USD 24.61 billion by 2030.

The market for diabetes injection pens encompasses devices used to administer insulin and other diabetes medications. These pens offer precise dosing, ease of use, and increased compliance, crucial for diabetes management. The necessity for these pens is driven by the rising prevalence of diabetes globally, an aging population, and patient preference for less invasive administration methods compared to traditional syringes. Application-wise, these pens are widely used by individuals with type 1 and type 2 diabetes and are available in disposable and reusable forms. Key end-users include hospitals, clinics, and homecare settings. Market growth is influenced by factors such as advancements in pen technology, which improve ease of use and accuracy, increasing consumer awareness about diabetes management, and expanding healthcare infrastructure in developing regions. Recent opportunities are powered by technological integration, such as Bluetooth-enabled pens that sync with mobile apps to track dosing patterns, providing a lucrative prospect for companies. Additionally, the development of pens capable of delivering biopharmaceuticals presents new avenues for innovation. However, market growth is challenged by high costs associated with diabetes treatment, stringent regulatory requirements, and concerns over needle phobia and potential side effects. Companies should focus on creating cost-effective, user-friendly devices with integrated digital solutions to remain competitive. Investing in research for needle-free options and biologics delivery can also open new revenue streams. Despite these challenges, the market is expected to see steady growth as companies harness opportunities through product diversification and strategic partnerships. As the market continues to evolve, embracing customization and patient-centric solutions will be key in capturing untapped segments and driving business growth. Overall, the market is competitive, with rapid advancements heralding significant potential for expansion and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Injection Pens Market

The Diabetes Injection Pens Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of diabetic patients worldwide
  • Demand for intelligent insulin pen
  • Growth in adoption of reusable diabetes injection pen
• Market Restraints
  • Limitation on using certain types of insulin through a pen
• Market Opportunities
  • Easy availability and convenience through e-commerce channel
  • Introduction of advanced diabetes injection pens
• Market Challenges
  • Risk of infection due to improper use

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Injection Pens Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Injection Pens Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Injection Pens Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Injection Pens Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Injection Pens Market

A detailed market share analysis in the Diabetes Injection Pens Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Injection Pens Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Injection Pens Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Injection Pens Market

A strategic analysis of the Diabetes Injection Pens Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Injection Pens Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Becton, Dickinson, and Company, Biocon Limited, Dexcom Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Haselmeier GmbH, Jiangsu Delfu Medical Device Co., Ltd., Medtronic PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, Owen Mumford Limited, Pfizer Inc., Sanofi S.A., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Diabetes Injection Pens Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Insulin Pens and Pen Needles.
• Based on Usage, market is studied across Disposable and Reusable.
• Based on Distribution Channel, market is studied across Diabetes Clinics, Hospital Pharmacy, Online Sales, and Retail Pharmacy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of diabetic patients worldwide
    • 5.1.1.2. Demand for intelligent insulin pen
    • 5.1.1.3. Growth in adoption of reusable diabetes injection pen
  • 5.1.2. Restraints
    • 5.1.2.1. Limitation on using certain types of insulin through a pen
  • 5.1.3. Opportunities
    • 5.1.3.1. Easy availability and convenience through e-commerce channel
    • 5.1.3.2. Introduction of advanced diabetes injection pens
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of infection due to improper use
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diabetes Injection Pens Market, by Product

• 6.1. Introduction
• 6.2. Insulin Pens
• 6.3. Pen Needles

7. Diabetes Injection Pens Market, by Usage

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Diabetes Injection Pens Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Diabetes Clinics
• 8.3. Hospital Pharmacy
• 8.4. Online Sales
• 8.5. Retail Pharmacy

9. Americas Diabetes Injection Pens Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Diabetes Injection Pens Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Diabetes Injection Pens Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca PLC
• 2. Becton, Dickinson, and Company
• 3. Biocon Limited
• 4. Dexcom Inc.
• 5. Eli Lilly and Company
• 6. F. Hoffmann-La Roche AG
• 7. Haselmeier GmbH
• 8. Jiangsu Delfu Medical Device Co., Ltd.
• 9. Medtronic PLC
• 10. Merck KGaA
• 11. Novartis AG
• 12. Novo Nordisk A/S
• 13. Owen Mumford Limited
• 14. Pfizer Inc.
• 15. Sanofi S.A.
• 16. Ypsomed Holding AG